Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Donald Trump
Biotech
Gone are the bear days for biotech? William Blair thinks so
The analyst’s optimism is rooted in continued M&A activity, with 2025's biopharma deal volume the highest recorded in the last decade.
Gabrielle Masson
Dec 12, 2025 10:55am
mRNA coalition demands stable FDA leadership amid vaccine changes
Dec 5, 2025 1:36pm
82% of industry CEOs concerned about FDA's abilities: survey
Nov 21, 2025 4:38pm
FDA unveils hiring spree, new comms program to speed reviews
Nov 21, 2025 11:43am
Fierce Healthcare
CDC updates website to promote debunked vaccine-autism link
Nov 20, 2025 4:20pm
NIH cuts disrupted hundreds of clinical trials, study finds
Nov 17, 2025 11:00am